866-997-4948(US-Canada Toll Free)

Global Pneumococcal Vaccine Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Oct 2018

Category :

Pharmaceutical

No. of Pages : 113 Pages

This report studies the global market size of Pneumococcal Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pneumococcal Vaccine in these regions.
This research report categorizes the global Pneumococcal Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015.
The second place is Europe, following North America with sales market share over 18% in 2016. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share in 2013, but the consumption experienced a sharp decrease due to approval of government departments in last few years.

In 2017, the global Pneumococcal Vaccine market size was 7140 million US$ and is forecast to 1263900 million US in 2025, growing at a CAGR of 91.0% from 2018. The objectives of this study are to define, segment, and project the size of the Pneumococcal Vaccine market based on company, product type, application and key regions.

The various contributors involved in the value chain of Pneumococcal Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Pneumococcal Vaccine include
Pfizer
GSK
MSD
Sanofipasteur
CDIBP

Market Size Split by Type
PPSV 23
PCV 7/13
PCV 10
Market Size Split by Application
Child
Adult

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Pneumococcal Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Pneumococcal Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pneumococcal Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pneumococcal Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Pneumococcal Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Pneumococcal Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pneumococcal Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Pneumococcal Vaccine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pneumococcal Vaccine Market Size Growth Rate by Type
1.4.2 PPSV 23
1.4.3 PCV 7/13
1.4.4 PCV 10
1.5 Market by Application
1.5.1 Global Pneumococcal Vaccine Market Size Growth Rate by Application
1.5.2 Child
1.5.3 Adult
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Pneumococcal Vaccine Market Size
2.1.1 Global Pneumococcal Vaccine Revenue 2016-2025
2.1.2 Global Pneumococcal Vaccine Sales 2016-2025
2.2 Pneumococcal Vaccine Growth Rate by Regions
2.2.1 Global Pneumococcal Vaccine Sales by Regions
2.2.2 Global Pneumococcal Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Pneumococcal Vaccine Sales by Manufacturers
3.1.1 Pneumococcal Vaccine Sales by Manufacturers
3.1.2 Pneumococcal Vaccine Sales Market Share by Manufacturers
3.1.3 Global Pneumococcal Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Pneumococcal Vaccine Revenue by Manufacturers
3.2.1 Pneumococcal Vaccine Revenue by Manufacturers (2016-2018)
3.2.2 Pneumococcal Vaccine Revenue Share by Manufacturers (2016-2018)
3.3 Pneumococcal Vaccine Price by Manufacturers
3.4 Pneumococcal Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pneumococcal Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pneumococcal Vaccine Product Category
3.4.3 Date of International Manufacturers Enter into Pneumococcal Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Pneumococcal Vaccine Sales by Type
4.2 Global Pneumococcal Vaccine Revenue by Type
4.3 Pneumococcal Vaccine Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Pneumococcal Vaccine Breakdown Data by Application

6 North America
6.1 North America Pneumococcal Vaccine by Countries
6.1.1 North America Pneumococcal Vaccine Sales by Countries
6.1.2 North America Pneumococcal Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pneumococcal Vaccine by Type
6.3 North America Pneumococcal Vaccine by Application
6.4 North America Pneumococcal Vaccine by Company

7 Europe
7.1 Europe Pneumococcal Vaccine by Countries
7.1.1 Europe Pneumococcal Vaccine Sales by Countries
7.1.2 Europe Pneumococcal Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pneumococcal Vaccine by Type
7.3 Europe Pneumococcal Vaccine by Application
7.4 Europe Pneumococcal Vaccine by Company

8 Asia Pacific
8.1 Asia Pacific Pneumococcal Vaccine by Countries
8.1.1 Asia Pacific Pneumococcal Vaccine Sales by Countries
8.1.2 Asia Pacific Pneumococcal Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pneumococcal Vaccine by Type
8.3 Asia Pacific Pneumococcal Vaccine by Application
8.4 Asia Pacific Pneumococcal Vaccine by Company

9 Central & South America
9.1 Central & South America Pneumococcal Vaccine by Countries
9.1.1 Central & South America Pneumococcal Vaccine Sales by Countries
9.1.2 Central & South America Pneumococcal Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pneumococcal Vaccine by Type
9.3 Central & South America Pneumococcal Vaccine by Application
9.4 Central & South America Pneumococcal Vaccine by Company

10 Middle East and Africa
10.1 Middle East and Africa Pneumococcal Vaccine by Countries
10.1.1 Middle East and Africa Pneumococcal Vaccine Sales by Countries
10.1.2 Middle East and Africa Pneumococcal Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pneumococcal Vaccine by Type
10.3 Middle East and Africa Pneumococcal Vaccine by Application
10.4 Middle East and Africa Pneumococcal Vaccine by Company

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Pneumococcal Vaccine
11.1.4 Pneumococcal Vaccine Product Description
11.1.5 Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Pneumococcal Vaccine
11.2.4 Pneumococcal Vaccine Product Description
11.2.5 Recent Development
11.3 MSD
11.3.1 MSD Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Pneumococcal Vaccine
11.3.4 Pneumococcal Vaccine Product Description
11.3.5 Recent Development
11.4 Sanofipasteur
11.4.1 Sanofipasteur Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Pneumococcal Vaccine
11.4.4 Pneumococcal Vaccine Product Description
11.4.5 Recent Development
11.5 CDIBP
11.5.1 CDIBP Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Pneumococcal Vaccine
11.5.4 Pneumococcal Vaccine Product Description
11.5.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Pneumococcal Vaccine Raw Material
13.1.2 Pneumococcal Vaccine Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Pneumococcal Vaccine
Figure Global Pneumococcal Vaccine Production (K Doses) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Pneumococcal Vaccine Production Market Share by Types (Product Category) in 2017
Figure PPSV 23 Product Picture
Table Major Manufacturers of PPSV 23
Figure PCV 7/13 Product Picture
Table Major Manufacturers of PCV 7/13
Figure PCV 10 Product Picture
Table Major Manufacturers of PCV 10
Table Global Pneumococcal Vaccine Market Size Growth Rate by Application 2018-2025 (K Doses)
Figure Child
Figure Adult
Figure Pneumococcal Vaccine Report Years Considered
Figure Global Pneumococcal Vaccine Market Size 2016-2025 (Million US$)
Figure Global Pneumococcal Vaccine Sales 2016-2025 (K Doses)
Table Global Pneumococcal Vaccine Market Size by Regions 2016-2025 (K Doses) & (Million US$)
Table Global Pneumococcal Vaccine Sales by Regions 2016-2025 (K Doses)
Table Global Pneumococcal Vaccine Sales Market Share by Regions 2016-2025
Figure Global Pneumococcal Vaccine Sales Market Share by Regions 2016-2025
Figure 2017 Global Pneumococcal Vaccine Sales Market Share by Regions
Table Global Pneumococcal Vaccine Revenue by Regions 2016-2025 (Million US$)
Table Global Pneumococcal Vaccine Revenue Market Share by Regions 2016-2025
Figure Global Pneumococcal Vaccine Revenue Market Share by Regions 2016-2025
Figure 2017 Global Pneumococcal Vaccine Revenue Market Share by Regions
Table Global Pneumococcal Vaccine Sales by Manufacturers (2016-2018) (K Doses)
Table Global Pneumococcal Vaccine Sales Share by Manufacturers (2016-2018)
Figure Global Pneumococcal Vaccine Sales Share by Manufacturers in 2017
Table Pneumococcal Vaccine Revenue by Manufacturers (2016-2018) (Million US$)
Table Pneumococcal Vaccine Revenue Share by Manufacturers (2016-2018)
Figure Pneumococcal Vaccine Value Share by Manufacturers in 2017
Table Global Pneumococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Pneumococcal Vaccine Price (2016-2018) (USD/Dose)
Table Pneumococcal Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Pneumococcal Vaccine Product Category
Table Date of International Manufacturers Enter into Pneumococcal Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Pneumococcal Vaccine Sales by Type (2016-2025) (K Doses)
Table Global Pneumococcal Vaccine Sales Share by Type (2016-2025)
Figure Global Pneumococcal Vaccine Sales Market Share by Type (2016-2025)
Figure Global Pneumococcal Vaccine Sales Market Share by Type in 2017
Table Global Pneumococcal Vaccine Revenue by Type (2016-2025) (Million US$)
Table Global Pneumococcal Vaccine Revenue Share by Type (2016-2025)
Figure Global Pneumococcal Vaccine Revenue Market Share by Type (2016-2025)
Figure Global Pneumococcal Vaccine Revenue Market Share by Type in 2017
Table Pneumococcal Vaccine Price by Type 2013-2018 (USD/Dose)
Table Global Pneumococcal Vaccine Sales by Application (2016-2025) (K Doses)
Table Global Pneumococcal Vaccine Sales Share by Application (2016-2025)
Figure Global Sales Pneumococcal Vaccine Market Share by Application (2016-2025)
Figure Global Sales Pneumococcal Vaccine Market Share by Application (2016-2025)
Figure North America Pneumococcal Vaccine Sales Growth Rate 2016-2025 (K Doses)
Figure North America Pneumococcal Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table North America Pneumococcal Vaccine Sales by Countries (2016-2025) (K Doses)
Table North America Pneumococcal Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 North America Pneumococcal Vaccine Sales Market Share by Countries
Table North America Pneumococcal Vaccine Revenue by Countries (2016-2025) (Million US$)
Table North America Pneumococcal Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Pneumococcal Vaccine Revenue Market Share by Countries
Figure United States Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure United States Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Canada Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Mexico Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table North America Pneumococcal Vaccine Sales by Type (2016-2025) (K Doses)
Table North America Pneumococcal Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 North America Pneumococcal Vaccine Market Share by Type
Table North America Pneumococcal Vaccine Sales by Application (2016-2025) (K Doses)
Table North America Pneumococcal Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 North America Pneumococcal Vaccine Market Share by Application
Table North America Pneumococcal Vaccine Sales by Company (2016-2018) (K Doses)
Table North America Pneumococcal Vaccine Sales Market Share by Company (2016-2018)
Figure North America Pneumococcal Vaccine Sales Market Share by Company in 2017
Figure Europe Pneumococcal Vaccine Sales Growth Rate 2016-2025 (K Doses)
Figure Europe Pneumococcal Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Pneumococcal Vaccine Sales by Countries (2016-2025) (K Doses)
Table Europe Pneumococcal Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Pneumococcal Vaccine Sales Market Share by Countries
Table Europe Pneumococcal Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Europe Pneumococcal Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Pneumococcal Vaccine Revenue Market Share by Countries
Figure Germany Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Germany Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (K Doses)
Figure France Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure France Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (K Doses)
Figure UK Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure UK Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Italy Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Russia Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Pneumococcal Vaccine Sales by Type (2016-2025) (K Doses)
Table Europe Pneumococcal Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Europe Pneumococcal Vaccine Market Share by Type
Table Europe Pneumococcal Vaccine Sales by Application (2016-2025) (K Doses)
Table Europe Pneumococcal Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Europe Pneumococcal Vaccine Market Share by Application
Table Europe Pneumococcal Vaccine Sales by Company (2016-2018) (K Doses)
Table Europe Pneumococcal Vaccine Sales Market Share by Company (2016-2018)
Figure Europe Pneumococcal Vaccine Sales Market Share by Company in 2017
Figure Asia Pacific Pneumococcal Vaccine Sales Growth Rate 2016-2025 (K Doses)
Figure Asia Pacific Pneumococcal Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Pneumococcal Vaccine Sales by Countries (2016-2025) (K Doses)
Table Asia Pacific Pneumococcal Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Pneumococcal Vaccine Sales Market Share by Countries
Table Asia Pacific Pneumococcal Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Pneumococcal Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Pneumococcal Vaccine Revenue Market Share by Countries
Figure China Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure China Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Japan Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Korea Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure India Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure India Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Australia Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Indonesia Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Malaysia Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Philippines Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Thailand Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Vietnam Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Singapore Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Pneumococcal Vaccine Sales by Type (2016-2025) (K Doses)
Table Asia Pacific Pneumococcal Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Pneumococcal Vaccine Market Share by Type
Table Asia Pacific Pneumococcal Vaccine Sales by Application (2016-2025) (K Doses)
Table Asia Pacific Pneumococcal Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Pneumococcal Vaccine Market Share by Application
Table Asia Pacific Pneumococcal Vaccine Sales by Company (2016-2018) (K Doses)
Table Asia Pacific Pneumococcal Vaccine Sales Market Share by Company (2016-2018)
Figure Asia Pacific Pneumococcal Vaccine Sales Market Share by Company in 2017
Figure Central & South America Pneumococcal Vaccine Sales Growth Rate 2016-2025 (K Doses)
Figure Central & South America Pneumococcal Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Pneumococcal Vaccine Sales by Countries (2016-2025) (K Doses)
Table Central & South America Pneumococcal Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Pneumococcal Vaccine Sales Market Share by Countries
Table Central & South America Pneumococcal Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Pneumococcal Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Pneumococcal Vaccine Revenue Market Share by Countries
Figure Brazil Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Brazil Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Argentina Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Pneumococcal Vaccine Sales by Type (2016-2025) (K Doses)
Table Central & South America Pneumococcal Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Pneumococcal Vaccine Market Share by Type
Table Central & South America Pneumococcal Vaccine Sales by Application (2016-2025) (K Doses)
Table Central & South America Pneumococcal Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Pneumococcal Vaccine Market Share by Application
Table Central & South America Pneumococcal Vaccine Sales by Company (2016-2018) (K Doses)
Table Central & South America Pneumococcal Vaccine Sales Market Share by Company (2016-2018)
Figure Central & South America Pneumococcal Vaccine Sales Market Share by Company in 2017
Figure Middle East and Africa Pneumococcal Vaccine Sales Growth Rate 2016-2025 (K Doses)
Figure Middle East and Africa Pneumococcal Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Pneumococcal Vaccine Sales by Countries (2016-2025) (K Doses)
Table Middle East and Africa Pneumococcal Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Pneumococcal Vaccine Sales Market Share by Countries
Table Middle East and Africa Pneumococcal Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries
Figure GCC Countries Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure GCC Countries Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Turkey Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Egypt Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Pneumococcal Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure South Africa Pneumococcal Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Pneumococcal Vaccine Sales by Type (2016-2025) (K Doses)
Table Middle East and Africa Pneumococcal Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Pneumococcal Vaccine Market Share by Type
Table Middle East and Africa Pneumococcal Vaccine Sales by Application (2016-2025) (K Doses)
Table Middle East and Africa Pneumococcal Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Pneumococcal Vaccine Market Share by Application
Table Middle East and Africa Pneumococcal Vaccine Sales by Company (2016-2018) (K Doses)
Table Middle East and Africa Pneumococcal Vaccine Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Pneumococcal Vaccine Sales Market Share by Company in 2017
Table Pfizer Company Details
Table Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table GSK Company Details
Table GSK Pneumococcal Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table GSK Recent Development
Table MSD Company Details
Table MSD Pneumococcal Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table MSD Recent Development
Table Sanofipasteur Company Details
Table Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Sanofipasteur Recent Development
Table CDIBP Company Details
Table CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table CDIBP Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Pneumococcal Vaccine Value Chain
Table Typical Suppliers of Key Pneumococcal Vaccine Raw Material
Table Pneumococcal Vaccine Customers List
Table Pneumococcal Vaccine Sales Channels
Table Pneumococcal Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *